Spain (ES)

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article Proteomic phenotyping with machine learning for cardiovascular outcomes in haemodialysis: insights from the AURORA trial (2026) Salib M, Girerd S, Pinet F, März W, Scharnagl H, Massy ZA, Leroy C, et al. Journal article Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study (2026) Zhang Q, Cai Y, Liu Y, Yao B, Sharma P, Ruoff E, Ma Z, et al. Journal article Facile preparation of environmentally relevant nano- and microplastics for hazard assessment and ecotoxicological testing evaluation (2026) Reinosa JJ, Guzmán JC, Fernández-Álvarez M, Katsumiti A, Roldan M, Hierhammer MY, Deloch L, et al. Journal article Multifunctional hybrid chitosan/κ-carrageenan sponges integrating engineered SBA-15@Fe3O4 composites and nano-hydroxyapatite for bone tissue engineering (2026) Vargas-Osorio Z, García-Acevedo P, Piñeiro Y, Michálek M, Luzardo-Álvarez A, Otero-Espinar FJ, Boccaccini AR, Rivas J Journal article Ellipsoidal particle transport and deposition in an averaged human nasal airway — A CFD study (2026) Wedel J, Catalán N, Steinmann P, Hriberšek M, Cito S, Varela S, Pallarès J, Ravnik J Journal article Oral nutritional interventions in hospitalised older people at nutritional risk: a network meta-analysis of individual participant data (2026) Kiesswetter E, Schwarzer G, Stadelmaier J, Lohner S, Grummich K, Dagnelie PC, Beck AM, et al. Journal article ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers (2026) Magno G, Rejeski K, Rappa G, Stock S, Holzem A, Landwehr M, Seib M, et al. Journal article MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer—a retrospective multi-center study analysis (2026) Papavramidis T, Chorti A, Bakkar S, Raffaelli M, Košec A, Hoang VT, Lim JY, et al. Journal article